@article{lacombe:hal-04761770,
  TITLE = {{Feasibility, safety, efficacy and potential scaling-up of sofosbuvir-based HCV treatment in Central and West Africa: (TAC ANRS 12311 trial).}},
  AUTHOR = {Lacombe, Karine and Moh, Raoul and Chazallon, Corine and Lemoine, Maud and Sylla, Babacar and Fadiga, Fatoumata and Le Carrou, Jer{\^o}me and Marcellin, Fabienne and Kouanfack, Charles and Ciaffi, Laura and Sartre, Michelle Tagni and Sida, Magloire Biwole and Diallo, Alpha and Gozlan, Joel and Seydi, Moussa and Ciss{\'e}, Viviane and Danel, Christine and Girard, Pierre Marie and Toni, Thomas d'Aquin and Minga, Albert and Boyer, Sylvie and Carrieri, Patrizia and Attia, Alain},
  URL = {https://hal.science/hal-04761770},
  JOURNAL = {{Scientific Reports}},
  PUBLISHER = {{Nature Publishing Group}},
  VOLUME = {14},
  NUMBER = {1},
  PAGES = {10244},
  YEAR = {2024},
  MONTH = May,
  DOI = {10.1038/s41598-024-57013-1},
  KEYWORDS = {Africa ; Clinical trial ; HIV ; Hepatitis C ; Sofosvubir ; Viral resistance},
  PDF = {https://hal.science/hal-04761770v1/file/BPH_SR_2024_Lacombe.pdf},
  HAL_ID = {hal-04761770},
  HAL_VERSION = {v1},
}